reckitt benckiser healthcare (central & eastern europe) limited
reckitt benckiser healthcare (central & eastern europe) limited Company Information
Company Number
03368448
Next Accounts
Sep 2025
Shareholders
reckitt benckiser treasury (2007) ltd
Group Structure
View All
Industry
Non-trading company
Registered Address
103-105 bath road, slough, berkshire, SL1 3UH
Website
https://www.booth.co.ukreckitt benckiser healthcare (central & eastern europe) limited Estimated Valuation
Pomanda estimates the enterprise value of RECKITT BENCKISER HEALTHCARE (CENTRAL & EASTERN EUROPE) LIMITED at £13.2m based on a Turnover of £9.5m and 1.39x industry multiple (adjusted for size and gross margin).
reckitt benckiser healthcare (central & eastern europe) limited Estimated Valuation
Pomanda estimates the enterprise value of RECKITT BENCKISER HEALTHCARE (CENTRAL & EASTERN EUROPE) LIMITED at £94.9m based on an EBITDA of £9.7m and a 9.81x industry multiple (adjusted for size and gross margin).
reckitt benckiser healthcare (central & eastern europe) limited Estimated Valuation
Pomanda estimates the enterprise value of RECKITT BENCKISER HEALTHCARE (CENTRAL & EASTERN EUROPE) LIMITED at £282.5m based on Net Assets of £209.3m and 1.35x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Reckitt Benckiser Healthcare (central & Eastern Europe) Limited Overview
Reckitt Benckiser Healthcare (central & Eastern Europe) Limited is a live company located in berkshire, SL1 3UH with a Companies House number of 03368448. It operates in the non-trading company sector, SIC Code 74990. Founded in May 1997, it's largest shareholder is reckitt benckiser treasury (2007) ltd with a 100% stake. Reckitt Benckiser Healthcare (central & Eastern Europe) Limited is a mature, mid sized company, Pomanda has estimated its turnover at £9.5m with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Reckitt Benckiser Healthcare (central & Eastern Europe) Limited Health Check
Pomanda's financial health check has awarded Reckitt Benckiser Healthcare (Central & Eastern Europe) Limited a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 1 areas for improvement. Company Health Check FAQs
5 Strong
0 Regular
1 Weak
Size
annual sales of £9.5m, make it larger than the average company (£3.8m)
£9.5m - Reckitt Benckiser Healthcare (central & Eastern Europe) Limited
£3.8m - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Reckitt Benckiser Healthcare (central & Eastern Europe) Limited
- - Industry AVG
Production
with a gross margin of 100%, this company has a lower cost of product (36%)
100% - Reckitt Benckiser Healthcare (central & Eastern Europe) Limited
36% - Industry AVG
Profitability
an operating margin of 102% make it more profitable than the average company (4.9%)
102% - Reckitt Benckiser Healthcare (central & Eastern Europe) Limited
4.9% - Industry AVG
Employees
with 30 employees, this is below the industry average (41)
- Reckitt Benckiser Healthcare (central & Eastern Europe) Limited
41 - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Reckitt Benckiser Healthcare (central & Eastern Europe) Limited
- - Industry AVG
Efficiency
resulting in sales per employee of £316.1k, this is more efficient (£154.3k)
- Reckitt Benckiser Healthcare (central & Eastern Europe) Limited
£154.3k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Reckitt Benckiser Healthcare (central & Eastern Europe) Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Reckitt Benckiser Healthcare (central & Eastern Europe) Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Reckitt Benckiser Healthcare (central & Eastern Europe) Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Reckitt Benckiser Healthcare (central & Eastern Europe) Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 1.3%, this is a lower level of debt than the average (47.6%)
1.3% - Reckitt Benckiser Healthcare (central & Eastern Europe) Limited
47.6% - Industry AVG
RECKITT BENCKISER HEALTHCARE (CENTRAL & EASTERN EUROPE) LIMITED financials
Reckitt Benckiser Healthcare (Central & Eastern Europe) Limited's latest turnover from December 2023 is £9.5 million and the company has net assets of £209.3 million. According to their latest financial statements, we estimate that Reckitt Benckiser Healthcare (Central & Eastern Europe) Limited has 30 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 9,483,000 | 2,689,000 | 1,382,000 | 1,070,000 | 413,000 | 791,000 | 950,000 | 1,132,000 | 3,158,000 | 8,227,000 | 9,174,000 | ||||
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | 180,000 | 373,000 | 2,508,000 | 5,334,000 | 2,000 | ||||||||||
| Gross Profit | 9,483,000 | 2,689,000 | 1,382,000 | 1,070,000 | 413,000 | 791,000 | 770,000 | 759,000 | 650,000 | 2,893,000 | 9,172,000 | ||||
| Admin Expenses | 1,070,000 | ||||||||||||||
| Operating Profit | |||||||||||||||
| Interest Payable | |||||||||||||||
| Interest Receivable | 561,000 | ||||||||||||||
| Pre-Tax Profit | 9,483,000 | 2,689,000 | 561,000 | 1,382,000 | 1,070,000 | 413,000 | 791,000 | 770,000 | 759,000 | 650,000 | 2,893,000 | 9,172,000 | |||
| Tax | -2,230,000 | -511,000 | -107,000 | -263,000 | -203,000 | -57,000 | 71,000 | 37,000 | -83,000 | 557,000 | -1,995,000 | -1,526,000 | |||
| Profit After Tax | 7,253,000 | 2,178,000 | 454,000 | 1,119,000 | 867,000 | 356,000 | 862,000 | 807,000 | 676,000 | 1,207,000 | 898,000 | 7,646,000 | |||
| Dividends Paid | |||||||||||||||
| Retained Profit | 7,253,000 | 2,178,000 | 454,000 | 1,119,000 | 867,000 | 356,000 | 862,000 | 807,000 | 676,000 | 1,207,000 | 898,000 | 7,646,000 | |||
| Employee Costs | |||||||||||||||
| Number Of Employees | |||||||||||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | |||||||||||||||
| Intangible Assets | |||||||||||||||
| Investments & Other | |||||||||||||||
| Debtors (Due After 1 year) | 199,864,000 | 196,247,000 | 182,237,000 | 187,216,000 | |||||||||||
| Total Fixed Assets | 199,864,000 | 196,247,000 | 182,237,000 | 187,216,000 | |||||||||||
| Stock & work in progress | |||||||||||||||
| Trade Debtors | |||||||||||||||
| Group Debtors | 212,024,000 | 202,541,000 | 199,959,000 | 200,221,000 | 198,539,000 | 197,469,000 | 197,056,000 | 196,265,000 | 197,015,000 | 14,687,000 | 6,815,000 | ||||
| Misc Debtors | |||||||||||||||
| Cash | |||||||||||||||
| misc current assets | |||||||||||||||
| total current assets | 212,024,000 | 202,541,000 | 199,959,000 | 200,221,000 | 198,539,000 | 197,469,000 | 197,056,000 | 196,265,000 | 197,015,000 | 14,687,000 | 6,815,000 | ||||
| total assets | 212,024,000 | 202,541,000 | 199,959,000 | 200,221,000 | 199,864,000 | 198,539,000 | 197,469,000 | 197,056,000 | 196,265,000 | 197,015,000 | 196,247,000 | 196,924,000 | 194,031,000 | ||
| Bank overdraft | |||||||||||||||
| Bank loan | |||||||||||||||
| Trade Creditors | |||||||||||||||
| Group/Directors Accounts | 2,741,000 | 511,000 | 107,000 | 369,000 | 466,000 | 260,000 | 57,000 | 71,000 | 1,628,000 | 1,536,000 | 3,420,000 | 1,425,000 | |||
| other short term finances | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| other current liabilities | |||||||||||||||
| total current liabilities | 2,741,000 | 511,000 | 107,000 | 369,000 | 466,000 | 260,000 | 57,000 | 71,000 | 1,628,000 | 1,536,000 | 3,420,000 | 1,425,000 | |||
| loans | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| Accruals and Deferred Income | |||||||||||||||
| other liabilities | |||||||||||||||
| provisions | |||||||||||||||
| total long term liabilities | |||||||||||||||
| total liabilities | 2,741,000 | 511,000 | 107,000 | 369,000 | 466,000 | 260,000 | 57,000 | 71,000 | 1,628,000 | 1,536,000 | 3,420,000 | 1,425,000 | |||
| net assets | 209,283,000 | 202,030,000 | 199,852,000 | 199,852,000 | 199,398,000 | 198,279,000 | 197,412,000 | 197,056,000 | 196,194,000 | 195,387,000 | 194,711,000 | 193,504,000 | 192,606,000 | ||
| total shareholders funds | 209,283,000 | 202,030,000 | 199,852,000 | 199,852,000 | 199,398,000 | 198,279,000 | 197,412,000 | 197,056,000 | 196,194,000 | 195,387,000 | 194,711,000 | 193,504,000 | 192,606,000 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | |||||||||||||||
| Depreciation | |||||||||||||||
| Amortisation | |||||||||||||||
| Tax | -2,230,000 | -511,000 | -107,000 | -263,000 | -203,000 | -57,000 | 71,000 | 37,000 | -83,000 | 557,000 | -1,995,000 | -1,526,000 | |||
| Stock | |||||||||||||||
| Debtors | 9,483,000 | 2,582,000 | -262,000 | 357,000 | 1,325,000 | 1,070,000 | 413,000 | 791,000 | -750,000 | 768,000 | -677,000 | 2,893,000 | 194,031,000 | ||
| Creditors | |||||||||||||||
| Accruals and Deferred Income | |||||||||||||||
| Deferred Taxes & Provisions | |||||||||||||||
| Cash flow from operations | 262,000 | -464,000 | -1,273,000 | ||||||||||||
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | |||||||||||||||
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | |||||||||||||||
| Group/Directors Accounts | 2,230,000 | 404,000 | -262,000 | -97,000 | 206,000 | 203,000 | 57,000 | -71,000 | -1,557,000 | 92,000 | -1,884,000 | 1,995,000 | 1,425,000 | ||
| Other Short Term Loans | |||||||||||||||
| Long term loans | |||||||||||||||
| Hire Purchase and Lease Commitments | |||||||||||||||
| other long term liabilities | |||||||||||||||
| share issue | |||||||||||||||
| interest | 561,000 | ||||||||||||||
| cash flow from financing | 2,230,000 | 404,000 | -262,000 | 464,000 | 206,000 | 203,000 | 57,000 | -71,000 | -1,557,000 | 92,000 | -1,884,000 | 1,995,000 | 186,385,000 | ||
| cash and cash equivalents | |||||||||||||||
| cash | |||||||||||||||
| overdraft | |||||||||||||||
| change in cash |
reckitt benckiser healthcare (central & eastern europe) limited Credit Report and Business Information
Reckitt Benckiser Healthcare (central & Eastern Europe) Limited Competitor Analysis
Perform a competitor analysis for reckitt benckiser healthcare (central & eastern europe) limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other mid companies, companies in SL1 area or any other competitors across 12 key performance metrics.
reckitt benckiser healthcare (central & eastern europe) limited Ownership
RECKITT BENCKISER HEALTHCARE (CENTRAL & EASTERN EUROPE) LIMITED group structure
Reckitt Benckiser Healthcare (Central & Eastern Europe) Limited has no subsidiary companies.
Ultimate parent company
2 parents
RECKITT BENCKISER HEALTHCARE (CENTRAL & EASTERN EUROPE) LIMITED
03368448
reckitt benckiser healthcare (central & eastern europe) limited directors
Reckitt Benckiser Healthcare (Central & Eastern Europe) Limited currently has 4 directors. The longest serving directors include Mr Richard Greensmith (Apr 2016) and Mr Timothy Martel (Jun 2020).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Richard Greensmith | 51 years | Apr 2016 | - | Director | |
| Mr Timothy Martel | United Kingdom | 50 years | Jun 2020 | - | Director |
| Mr James Hodges | United Kingdom | 47 years | Dec 2020 | - | Director |
| Mr Stephen Pickstone | United Kingdom | 47 years | Feb 2024 | - | Director |
P&L
December 2023turnover
9.5m
+253%
operating profit
9.7m
0%
gross margin
100%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
209.3m
+0.04%
total assets
212m
+0.05%
cash
0
0%
net assets
Total assets minus all liabilities
reckitt benckiser healthcare (central & eastern europe) limited company details
company number
03368448
Type
Private limited with Share Capital
industry
74990 - Non-trading company
incorporation date
May 1997
age
28
incorporated
UK
ultimate parent company
accounts
Audit Exemption Subsidiary
last accounts submitted
December 2023
previous names
boots healthcare central & eastern europe limited (April 2006)
speed 6364 limited (June 1997)
accountant
-
auditor
-
address
103-105 bath road, slough, berkshire, SL1 3UH
Bank
-
Legal Advisor
-
reckitt benckiser healthcare (central & eastern europe) limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to reckitt benckiser healthcare (central & eastern europe) limited.
reckitt benckiser healthcare (central & eastern europe) limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for RECKITT BENCKISER HEALTHCARE (CENTRAL & EASTERN EUROPE) LIMITED. This can take several minutes, an email will notify you when this has completed.
reckitt benckiser healthcare (central & eastern europe) limited Companies House Filings - See Documents
| date | description | view/download |
|---|
